Over the past 12 months, $ROIV generated 5 mentions from 2 distinct FinTwit voices, with biotech analyst @adamfeuerstein accounting for 3 mentions and @yasutaketin contributing 2 mentions. The first mention appeared on 2025-12-23, with the most recent activity clustered around early March 2026. The ticker's discussion centered on a major development: Moderna's settlement with Roivant regarding mRNA vaccine patent litigation involving lipid nanoparticle delivery technology.